Business October 7, 2026 at 5:03 PM

Sun Pharma to consider ₹15,000 crore NCD issue; board meeting on 12 October

Livemint Markets

Sun Pharmaceutical Industries will hold a Board meeting on October 12, 2026, to approve the issuance of non-convertible debentures worth up to ₹15,000 crore to fund a bridge loan for acquiring Organon & Co.

Excerpt from Livemint Markets.

Read the full story at Livemint Markets

More Stories

Business

Adani Enterprises: AEL gets highest-ever rating in its credit history; shares up over 22% YTD

Adani Enterprises has achieved an upgraded long-term rating of AA Stable, marking its highest credit rating in history, …

🇮🇳 Livemint Markets 52m ago

Business

RBI’s big move: Your consolidated account statement will now have details of MFs, stocks & FDs!

For individuals who receive a CAS, this means information on their mutual funds, stocks and, going forward, fixed deposi…

🇮🇳 TOI Business 2h ago

Business

Why are Dow, S&P 500 and Nasdaq falling as Treasury yields hit 24-year high?

Dow, S&P 500 and Nasdaq fall as 10-year Treasury yields hit a 24-year high, while oil prices, inflation worries and Fed …

🇮🇳 Hindustan Times Business 2h ago

Your world briefing, in your pocket

Curated news from 12 countries and 10 languages. Coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play